Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00505
|
|||||
| Drug Name |
Cilastatin
|
|||||
| Synonyms |
(2Z)-7-{[(2R)-2-amino-2-carboxyethyl]sulfanyl}-2-({[(1S)-2,2-dimethylcyclopropyl]carbonyl}amino)hept-2-enoic acid; (Z)-(S)-6-carboxy-6-[(S)-2,2-dimethylcyclopropanecarboxamido]hex-5-enyl-L-cysteine; (Z)-7-[(2R)-2-amino-3-hydroxy-3-oxopropyl]sulfanyl-2-[[(1S)-2,2-dimethylcyclopropanecarbonyl]amino]hept-2-enoic acid; Cilastatin (INN); Cilastatin Monosodium Salt; Cilastatin [INN:BAN]; Cilastatin acid; Cilastatina; Cilastatina [Spanish]; Cilastatine; Cilastatine [French]; Cilastatinum; Cilastatinum [Latin]; MK-791; MK0791
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Bacterial infections [ICD11: 1A00-1H0Z] | Unclear | ||||
| Therapeutic Class |
Antibiotics
|
|||||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C16H26N2O5S
|
|||||
| Canonical SMILES |
CC1(CC1C(=O)NC(=CCCCCSCC(C(=O)O)N)C(=O)O)C
|
|||||
| InChI |
InChI=1S/C16H26N2O5S/c1-16(2)8-10(16)13(19)18-12(15(22)23)6-4-3-5-7-24-9-11(17)14(20)21/h6,10-11H,3-5,7-9,17H2,1-2H3,(H,18,19)(H,20,21)(H,22,23)/b12-6-/t10-,11+/m1/s1
|
|||||
| InChIKey |
DHSUYTOATWAVLW-WFVMDLQDSA-N
|
|||||
| CAS Number |
CAS 82009-34-5
|
|||||
| Pharmaceutical Properties | Molecular Weight | 358.5 | Topological Polar Surface Area | 155 | ||
| Heavy Atom Count | 24 | Rotatable Bond Count | 11 | |||
| Hydrogen Bond Donor Count | 4 | Hydrogen Bond Acceptor Count | 7 | |||
| XLogP |
-1
|
|||||
| PubChem CID | ||||||
| PubChem SID |
103203584
, 104133316
, 114548412
, 11621425
, 126628216
, 126655280
, 126671064
, 131327190
, 134222536
, 134337922
, 135014438
, 137129408
, 137256909
, 142803744
, 14803328
, 152101563
, 15447933
, 160846604
, 160964834
, 175267016
, 178101856
, 179680678
, 196105993
, 223682361
, 226422952
, 250133500
, 43028732
, 46505611
, 4819
, 49835265
, 49975600
, 50125939
, 50707339
, 51091997
, 57367468
, 92719468
, 93166940
, 93578311
|
|||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | OAT1 | Transporter Info | Organic anion transporter 1 | Substrate | [1] | |
| OAT3 | Transporter Info | Organic anion transporter 3 | Substrate | [1] | ||
| References | ||||||
| 1 | Organic anion transporters also mediate the drug-drug interaction between imipenem and cilastatin. Asian J Pharm Sci. 2020 Mar;15(2):252-263. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.